Abstract:
A robotic workstation includes apparatus for actuating one or more syringes. Each syringe has a cylinder and a plunger movable in the cylinder. A programmable robot has at least one syringe actuating device. The actuating device has a holder for holding and releasing a syringe cylinder and an actuator movable relative to the holder. A coupling couples the actuator to the plunger of the syringe such that, when the cylinder is held by the holder, movement of the actuator relative to the holder causes the plunger to move in the cylinder. A method of dispensing a material into a container includes robotically moving at least one syringe to a position for dispensing into a container. The plunger is robotically moved in the cylinder to dispense material from the syringe into the container. The workstation suitably includes a mixing apparatus for mixing materials in an array of containers at the workstation.
Abstract:
The synthesis of a crystalline material, in particular, a high silica zeolite, comprising a chabazite-type framework molecular sieve is conducted in the presence of an organic directing agent having the formula: [R1R2R3N—R4]+Q− wherein R1 and R2 are independently selected from hydrocarbyl groups and hydroxy-substituted hydrocarbyl groups having from 1 to 3 carbon atoms, provided that R1 and R2 may be joined to form a nitrogen-containing heterocyclic structure, R3 is an alkyl group having 2 to 4 carbon atoms and R4 is selected from a 4- to 8-membered cycloalkyl group, optionally, substituted by 1 to 3 alkyl groups each having from 1 to 3 carbon atoms; and a 4- to 8-membered heterocyclic group having from 1 to 3 heteroatoms, said heterocyclic group being, optionally, substituted by 1 to 3 alkyl groups each having from 1 to 3 carbon atoms and the or each heteroatom in said heterocyclic group being selected from the group consisting of O, N, and S, or R3 and R4 are hydrocarbyl groups having from 1 to 3 carbon atoms joined to form a nitrogen-containing heterocyclic structure; and Q− is a anion.
Abstract:
A selective hydrogenation catalyst composition comprises a support; a first metal component comprising rhodium; and a second metal component comprising a metal other than rhodium and selected from Groups 1 to 15 of the Periodic Table of Elements, wherein said first and second components are predominantly contained in an outer surface layer of the support having a depth of not more than 1000 microns.
Abstract:
A selective hydrogenation catalyst composition comprises a support; a first metal component comprising rhodium; and a second metal component comprising a metal other than rhodium and selected from Groups 1 to 15 of the Periodic Table of Elements, wherein said first and second components are predominantly contained in an outer surface layer of the support having a depth of not more than 1000 microns.
Abstract:
A selective hydrogenation catalyst composition comprises a rhodium component present in an amount such that the catalyst composition comprises less than 3.0% of rhodium by weight of the total catalyst composition; and an indium component present in an amount such that the catalyst composition comprises at least 0.3% and less than 5.0% of indium by weight of the total catalyst composition.
Abstract:
An selective hydrogenation catalyst composition comprises a rhodium component present in an amount such that the catalyst composition comprises less than 3.0% of rhodium by weight of the total catalyst composition; and an indium component present in an amount such that the catalyst composition comprises at least 0.3% and less than 5.0% of indium by weight of the total catalyst composition.
Abstract:
A method is disclosed of synthesizing a crystalline material comprising a CHA framework type molecular sieve and having a composition involving the molar relationship: (n)X2O3:YO2, wherein X is a trivalent element; Y is a tetravalent element; and n is from 0 to less than 0.01. The method comprises preparing a reaction mixture capable of forming said material, said mixture comprising a source of water, a source of an oxide of a tetravalent element Y and optionally a source of an oxide of a trivalent element X, wherein the reaction mixture is substantially free of fluoride ions added as HF; maintaining the reaction mixture under conditions sufficient to form crystals of the crystalline material; and than recovering the crystalline material. The reaction mixture comprises either a specific directing agent for directing the formation of a CHA framework type molecular sieve and/or a H2O:YO2 molar ratio of greater than 20. In one embodiment, the resultant crystalline material is free of stacking faults and/or any intergrown phase with an AEI framework type molecular sieve.
Abstract translation:公开了一种合成包含CHA骨架型分子筛并具有摩尔关系的组成的结晶材料的方法:<?in-line-formula description =“In-line Formulas”end =“lead”?>(n) Y 2,Y 2,Y 2,Y 2,Y 3,Y 2,Y 2, >其中X是三价元素; Y是四价元素; 并且n为0至小于0.01。 该方法包括制备能够形成所述材料的反应混合物,所述混合物包含水源,四价元素Y的氧化物源和任选的三价元素X的氧化物源,其中反应混合物基本上 不含氟离子作为HF添加; 在足以形成结晶材料晶体的条件下保持反应混合物; 而不是回收结晶材料。 反应混合物包含用于引导形成CHA骨架型分子筛和/或H 2 O 2 Y 2/2摩尔比大于20的特异性导向剂 在一个实施方案中,所得结晶材料与AEI框架型分子筛不含堆垛层错和/或任何共生相。
Abstract:
A selective hydrogenation catalyst composition comprises at least two different metal components selected from Groups 8 to 10 of the Periodic Table of Elements, one of which may be rhodium, and at least one metal component selected from Group 13 of the Periodic Table of Elements, such as indium.
Abstract:
The subject invention provides polynucleotide sequences, designated BIVM, and transcriptional/translational products obtained from the polynucleotide sequences of the invention. The subject invention also provides polynucleotide and polypeptide sequences provided by SEQ ID NOs:1-28. Also provided are methods of detecting the presence of BIVM nucleic acids or polypeptides in samples suspected of containing BIVM genes, BIVM transcriptional products, or BIVM translational products. These methods are also useful for the detection of BIVM orthologs. Other embodiments provide polypeptide and/or nucleic acid vaccines for the induction of an immune response to in an individual. Kits for detecting the presence of BIVM genes, orthologs thereof, BIVM polypeptides, or BIVM transcriptional products are also provided.
Abstract:
The synthesis of a crystalline material, in particular a high silica zeolite, having a chabazite-type framework is aided by the addition to the synthesis mixture of seeds of an AEI framework-type material. The chabazite-type product has a relatively small crystal size and exhibits activity and selectivity in the conversion of methanol to lower olefins, especially ethylene and propylene.